Profil
Richard S.
Shames worked as a Senior Medical Director at Abbott Biotherapeutics Corp.
from 1999 to 2009, followed by a position as Scientist-Clinical Research at Merck & Co., Inc. from 2009 to 2013.
He then served as Chief Medical Officer at Aldea Pharmaceuticals, Inc. from 2013 to 2015 and later as Chief Medical Officer at Protagonist Therapeutics, Inc. from 2015 to 2019.
Prior to his industry positions, he was an Assistant Clinical Professor-Pediatrics at Stanford University and the University of California.
Shames received his undergraduate degree from Stanford University and his doctorate from the University of California.
Anciens postes connus de Richard S. Shames
| Sociétés | Poste | Fin |
|---|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 09/05/2019 |
Aldea Pharmaceuticals, Inc.
Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel enzyme activators to enhance the removal of toxic aldehydes | Directeur Technique/Scientifique/R&D | 01/01/2015 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2013 |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Corporate Officer/Principal | 01/01/2009 |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Richard S. Shames
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Health Technology |
Aldea Pharmaceuticals, Inc.
Aldea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel enzyme activators to enhance the removal of toxic aldehydes | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Protagonist Therapeutics, Inc.
Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















